- Telehealth Visits
- Insurance plan information
Samuel L. Washington, MD
Urologic Oncology- Telehealth Visits
- Insurance plan information
Samuel L. Washington, MD
Urologic Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Samuel L. Washington III is a urologic surgeon who specializes in oncology. He cares for patients with cancers of the genital and urinary organs, including prostate, bladder and kidney cancers.
In his research, Washington studies patient outcomes after cancer treatment, looking particularly at how differences in treatment impact survival outcomes for individuals with genital and urinary cancers.
Washington earned his medical degree, completed a residency in urology and completed a fellowship in urologic oncology at UCSF. He also has a master of advanced study degree in clinical research from UCSF.
Education & training
Board certification
- Urology, American Board of Urology
Residency
- Urology, UCSF Graduate Medical Education
Internship
- General Surgery, UCSF Graduate Medical Education
Degree
- MD, UCSF School of Medicine
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 107 reviews
- January 24, 20265 out of 5 Stars
Great Doctor
- January 13, 20265 out of 5 Stars
Great team always keeping me informed
- January 9, 20265 out of 5 Stars
Excellent treatment by Dr. Washington and team from start to finish.
- January 9, 20265 out of 5 Stars
Dr. Washington is excellent!
- January 9, 20265 out of 5 Stars
Dr. Washington used internet images to clarify the best solution and referred to others in his team for further treatments.
- December 28, 20255 out of 5 Stars
Dr. Washington has been amazing, very knowledgeable, professional and very kind.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.